U.S. markets open in 34 minutes
  • S&P Futures

    3,426.50
    -6.00 (-0.17%)
     
  • Dow Futures

    28,094.00
    -40.00 (-0.14%)
     
  • Nasdaq Futures

    11,673.75
    -17.50 (-0.15%)
     
  • Russell 2000 Futures

    1,607.60
    +4.50 (+0.28%)
     
  • Crude Oil

    40.18
    +0.15 (+0.37%)
     
  • Gold

    1,907.80
    -21.70 (-1.12%)
     
  • Silver

    24.76
    -0.48 (-1.89%)
     
  • EUR/USD

    1.1832
    -0.0035 (-0.30%)
     
  • 10-Yr Bond

    0.8080
    -0.0080 (-0.98%)
     
  • Vix

    29.17
    -0.18 (-0.61%)
     
  • GBP/USD

    1.3111
    -0.0033 (-0.25%)
     
  • USD/JPY

    104.5900
    +0.0300 (+0.03%)
     
  • BTC-USD

    12,862.32
    +1,805.31 (+16.33%)
     
  • CMC Crypto 200

    259.23
    +14.34 (+5.86%)
     
  • FTSE 100

    5,766.98
    -9.52 (-0.16%)
     
  • Nikkei 225

    23,474.27
    -165.19 (-0.70%)
     

Brazil's Hypera to sell Xantinon drug to Uniao Quimica

SAO PAULO, Sept 26 (Reuters) - Brazilian pharmaceutical company Hypera SA has reached an agreement to sell the medicine Xantinon to Uniao Quimica Farmaceutica Nacional SA for 95 million reais ($17.08 million), according to a securities filing late on Friday.

Xantinon was part of a portfolio of 18 products Hypera acquired from Japan's Takeda Pharmaceutical Co for $825 million earlier in March.

($1 = 5.5610 reais) (Reporting by Carolina Mandl; Editing by Andrew Heavens)